Skip to content
School of Law

Gregory Dolin

Associate ProfessorGregory Dolin
Co-Director of the Center for Medicine and Law

gdolin@ubalt.edu
410.837.4610, Angelos Law 539

Administrative Assistant: Gloria Joy
410.837.4631, Angelos Law 518

Education

J.D., Georgetown University Law Center
M.D., State University of New York at Stony Brook School of Medicine
B.A., Johns Hopkins University

Curriculum Vitae

Areas of Expertise

Property
Torts
Patents
Intellectual Property
Healthcare Law

Professor Dolin is co-director of the Center for Medicine and Law. The center supports collaboration between experts in the fields of both medicine and law, and focus its efforts on an examination of medical and legal issues from the perspective of the health care practitioner. Professor Dolin's primary research interests are at the intersection of patent and healthcare law.

The center, with the Johns Hopkins Medical Institutions, operates the JHU/UB School of Law Joint Program for Medicine and the Law. The program aims to shift the focus from the courtroom to the classroom by empowering health providers, attorneys and other stakeholders to work together in a collaborative setting on health law issues.

Prior to joining the University of Baltimore School of Law, Dr. Dolin held a position at George Washington University Law School as a Frank H. Marks Visiting Associate Professor of Law and Administrative Fellow in the Intellectual Property Program. He was a law clerk to the Hon. Pauline Newman of the U.S. Court of Appeals for the Federal Circuit and the late Hon. H. Emory Widener, Jr. of the U.S. Court of Appeals for the Fourth Circuit. He served as a John M. Olin Fellow in Law at Northwestern University School of Law, and as an associate in the intellectual property group of Kramer, Levin, Naftalis, and Frankel LLP.

Selected Publications

Articles and Essays

Speaking of Science: Introducing Notice-and-Comment into the Legislative Process, 2014 Utah L.R.___ (forthcoming)

Exclusivity Without Patents: The New Frontier of FDA Regulation for Genetic Materials, 98 Iowa L.R. 1399 (2013) 

Reverse Settlements as Patent Invalidity Signals, 24 Harvard J. L. & Tech 281 (2011)

A Defense of Embryonic Stem Cell Research, 84 Ind. L.J. 1203 (2009)

Medical hope, legal pitfalls: Potential legal issues in the emerging field of oncofertility, 49 Santa Clara L. Rev. 673 (2009)

 



Articles on Social Science Research Network